VICTORY CAPITAL MANAGEMENT INC

Position in ZYME — Zymeworks Inc.

CIK 1040188 San Antonio, TX

Position in ZYME

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,061,796

-$67,892 QoQ

Shares Held

42,404

-1.2% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. ZYME ranks #70 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,888,521	$843,300,167
2	RPRX	Royalty Pharma plc	3,853,808	$184,867,169
3	INCY	Incyte Corp	1,742,870	$164,038,924
4	REGN	Regeneron Pharmaceuticals, Inc.	129,074	$99,727,735
5	ALNY	Alnylam Pharmaceuticals, Inc.	195,937	$64,829,675
6	INSM	INSMED Inc	396,245	$64,793,982
7	LGND	Ligand Pharmaceuticals Inc	303,224	$60,538,671
8	JAZZ	Jazz Pharmaceuticals plc	256,598	$48,509,851

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,061,796	42,404	-1.2%	Shares	Sole	2026-05-15
2025-12-31	$1,129,688	42,905	+24.3%	Shares	Sole	2026-02-13
2025-09-30	$589,430	34,510	-0.3%	Shares	Sole	2025-11-12
2025-06-30	$434,355	34,610	-21.8%	Shares	Sole	2025-08-13
2025-03-31	$527,255	44,270	-14.2%	Shares	Sole	2025-05-02
2024-12-31	$755,131	51,580	-5.2%	Shares	Sole	2025-02-06
2024-09-30	$682,594	54,390	-6.7%	Shares	Sole	2024-11-05
2024-06-30	$496,133	58,300	+23.5%	Shares	Sole	2024-08-05
2024-03-31	$496,544	47,200	-61.7%	Shares	Sole	2024-05-03
2023-06-30	$1,065,398	123,310	-18.8%	Shares	Sole	2023-07-27
2023-03-31	$1,373,628	151,950	—	Shares	Sole	2023-05-02
No filing history on record for this holder in this stock.